Professor Anthony Lawler, Australian Government Chief Medical Officer, 
This CPD activity is supported by an unrestricted education grant by Reckitt.[/caption]
Case scenario
Jess Hadley, community pharmacist and Professional Officer at PDL[/caption]
Peter Guthrey, Senior Pharmacist – Strategic Policy at PSA[/caption]
GP Pharmacists change views on pharmacy scope of care
Having a pharmacist in a general practice can be a powerful tool for changing other healthcare practitioners' attitudes towards pharmacy scope of care, a...
Overprescribing of psychotropics for adults with autism
Adults on the autism spectrum are often prescribed psychotropic medication to manage behaviour, despite limited evidence to support this practice, a new report has...
Young sparks light up pharmacy future
The future of pharmacy is bright, engaged and passionate, the search for the latest PSA MIMS Intern Pharmacist of the Year has revealed.
Judges were...
Complementary medicines: Rheumatoid arthritis
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by joint inflammation. The immune system attacks the tissue lining the joints (synovial membrane), causing...
Efficacy of antiplatelets in deep venous thrombosis
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.
A breast cancer drug for seizures
Status epilepticus is a medical emergency. It is commonly defined as 30 minutes of continuous seizure activity, or repeated seizures without full recovery of...
